Anthony Boral
2019
In 2019, Anthony Boral earned a total compensation of $2.6M as Chief Medical Officer at Blueprint Medicines, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $194,945 |
|---|---|
| Option Awards | $1,366,786 |
| Salary | $460,864 |
| Stock Awards | $606,200 |
| Other | $8,400 |
| Total | $2,637,195 |
Boral received $1.4M in option awards, accounting for 52% of the total pay in 2019.
Boral also received $194.9K in non-equity incentive plan, $460.9K in salary, $606.2K in stock awards and $8.4K in other compensation.
Rankings
In 2019, Anthony Boral's compensation ranked 4,634th out of 13,971 executives tracked by ExecPay. In other words, Boral earned more than 66.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,634 out of 13,971 | 67th |
Division Manufacturing | 1,729 out of 5,701 | 70th |
Major group Chemicals And Allied Products | 606 out of 2,200 | 73rd |
Industry group Drugs | 510 out of 1,886 | 73rd |
Industry Pharmaceutical Preparations | 384 out of 1,398 | 73rd |
Pay ratio
| Anthony Boral's Pay | $2,637,195 |
|---|---|
| Median Employee's Pay | $360,897 |
| Pay Ratio | 7to 1 |
In 2019, the annual total compensation of Anthony Boral was $2,637,195.
The annual total compensation of the median employee at Blueprint Medicines was $360,897.
The ratio of Anthony Boral's pay to the pay of median employee was therefore 7 to one.
Source: SEC filing on April 29, 2020.
Boral's colleagues
We found four more compensation records of executives who worked with Anthony Boral at Blueprint Medicines in 2019.